Anti-tumor effect of polymer nano-platinum(Ⅳ) in vivo and vitro
Jie HOU,Cheng-bin JIAO,Jin-cai SHANG,Xiao-li ZHANG,Lan LUO
DOI: https://doi.org/10.11675/j.issn.0253-4304.2018.02.18
2018-01-01
Abstract:Objective To explore the anti-tumor effect of polymer nano-platinum(Ⅳ) on the mice with orthotopic liver cancer as well as its inhibitory effect on the cell activity of liver cancer. Methods (1) One hundred mice were enrolled to develop the mouse model of orthotopic liver cancer, and 36 liver cancer mice with successful modeling were divided into polymer nano-platinum (Ⅳ) group and oxaliplatin(Ⅱ) group,with 18 mice in each group. The two groups were treated with corresponding drugs. After 1,3,6,9,12,24 hours of intervention,the mice were sacrificed in batches,and the contents of platinum drugs in heart,liver,spleen,lung and kidney of mice were determined by inductively coupled plasma optical emission spectrometry. ( 2 ) Fifty-four liver cancer mice with successful modeling were divided into blank control group,polymer nano-platinum(Ⅳ) group and oxaliplatin(Ⅱ) group,with 18 mice in each group. The intervention groups were given corresponding drugs, while the blank control group was given an equivalent volume of normal saline. The mice were sacrificed in batches on the 1st,3rd,5th,7th,9th and 11th day after intervention,respectively,and tumor tissues were taken to measure the tumor volume. (3) The HepG-2 cells of logarithmic phase were divided into blank control group,0. 1 μg/ml,1 μg/ml,10 μg/ml and 100 μg/ml oxaliplatin(Ⅱ) groups,and 0. 1 μg/ml,1 μg/ml,10 μg/ml and 100 μg/ml polymer nano-platinum(Ⅳ) groups. The intervention groups were given corresponding concentrations of oxaliplatin (Ⅱ) or polymer nano-platinum (Ⅳ) , while the blank control group was given an equivalent volume of medium. After 48 and 72 hours of further culture,the cell activity was detected by methyl thiazolyl tetrazolium assay respectively. Results (1) After one hour of intervention,the content of platinum drugs in the liver and kidney tissues of mice in the oxaliplatin(Ⅱ) group was at the highest level,and the content of platinum drugs in liver tissues decreased with the increasing intervention time;the content of platinum drugs in liver tissues in the polymer nano-platinum(Ⅳ) group remained at a stable level,and the content of platinum drugs in renal tissues decreased significantly after six hours of intervention compared to the content at one hour after intervention. (2) The liver tumors of mice in the blank control group grew rapidly over time. The liver tumors of mice grew slowly in the oxaliplatin(Ⅱ) group and polymer nano-platinum(Ⅳ) group,no obvious growth of tumor was seen after 11 days of intervention,and the tumor volume presented a decreasing trend in the polymer nanoplatinum(Ⅳ) group since the 3rd day of intervention. (3) The activity of HepG-2 cells was lower after 48 hours of intervention but was higher after 72 hours of intervention in the oxaliplatin(Ⅱ) group compared to the activity in the polymer nano-platinum(Ⅳ) group. Conclusion Polymer nano-platinum(Ⅳ) has better therapeutic effects on the mice with orthotopic liver cancer.